Skip to main content
. 2021 Dec 16;8:793040. doi: 10.3389/fmed.2021.793040

Figure 6.

Figure 6

miRNA alteration in HSPCs after MM-EV interaction. (A) Digital PCR analysis for miR-21, miR-34a, miR-150, and miR-155 on HSPCs treated and not with 400 μg MM-derived EVs (the higher dose). (B) The target genes of hsa-miRNAs were analyzed by the bioinformatics tool miRTargetLink human. The central node represents miR-21, miR-34a, miR-150, and miR-155, and it was surrounded by the validated target with strong evidence. The bar graphs represent the average of three replicates. (C) The table showed miR-21, miR-150, and miR-155 amount as copies/μl of dPCR reaction mix and copies/ng of EV-RNA in EVs. MM, multiple myeloma; EVs, Extracellular vesicles; HSPC, hematopoietic stem and progenitor cells.